MB
VERV
MPM BioImpact’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-638,163
| Closed | -$3.11M | – | 52 |
|
|
2024
Q2 | $3.11M | Hold |
638,163
| – | – | 0.48% | 43 |
|
|
2024
Q1 | $8.47M | Hold |
638,163
| – | – | 1.36% | 28 |
|
|
2023
Q4 | $8.9M | Sell |
638,163
-219,777
| -26% | -$3.06M | 2.08% | 23 |
|
|
2023
Q3 | $11.4M | Hold |
857,940
| – | – | 3.04% | 12 |
|
|
2023
Q2 | $16.1M | Buy |
857,940
+54,439
| +7% | +$1.02M | 3.24% | 11 |
|
|
2023
Q1 | $11.6M | Sell |
803,501
-5,160
| -0.6% | -$74.4K | 3.01% | 13 |
|
|
2022
Q4 | $15.6M | Buy |
808,661
+172,869
| +27% | +$3.35M | 4.06% | 9 |
|
|
2022
Q3 | $21.8M | Buy |
+635,792
| New | +$21.8M | 5.17% | 4 |
|